Type Whole antibody Target IL6 CAS Number 1007223-17-7 | Source Humanized ATC code none ChemSpider none | |
Olokizumab is an immunomodulator. It binds to interleukin 6. Hence acting as an Anti-IL-6 therapeutic aimed at inflammatory disease e.g. rheumatoid arthritis (RA).
It had promising results in a phase II trial against placebo or tocilizumab for patients with moderate to severe RA.
References
Olokizumab Wikipedia(Text) CC BY-SA